Because the perforin/granzyme B pathway has been implicated in potential mechanisms of oligodendrocyte and/or axonal injury and demyelination in MS [7], our findings together suggest that increased HGF may reduce CTL effector function in CTL-mediated human autoimmune disorders of the CNS. This evidence concerns the gene PRF1 and myeloid sarcoma.